The Ebola outbreak in West Africa has dominated recent newscasts and shocked many people with the speed and ferocity of its spread. Any such outbreak raises questions…
As we’ve discussed, Eric Topol’s “How to Change Medicine” provides valuable insights on how tailoring treatments in the clinic could boost health care effectiveness and lower costs. But…
There appears to be a full-scale race underway to bring affordable next-gen DNA sequencing into diagnostics and clinical medicine, as demonstrated over the past week or so…
Last week, we discussed new drug approvals that reflected a paradigm shift for cancer drug development and for treatment of people living with cancer. Finally, we are…
In a recent paper that spawned news articles and blogs worldwide, researchers announced the generation of human embryos that could produce stem cells. The announcement marks another step in the use…
In his latest Wall Street Journal column (“Drugs That Are as Smart as Our Diseases”), biologist/author Matt Ridley bemoans the plummeting efficiency of drug discovery in the…
It’s increasingly clear to anyone who deals with human health – from the bench biologist to the clinical oncologist – that humans are a heterogeneous species. As…
For the thousands of life science industry representatives who attend the Biotechnology Industry Organization Annual Convention each year, the last few days have been similar to a favorite ho…
